REFERENCES
- Weiner, W.J. (2006). Myotonia congenita—a cause of muscle weakness and stiffness. Nat Clin. Pract. Neurol. 70: 393–399.
- Guigoni, C., Dovero, S., Aubert, I. (2005). Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning. Eur J Neurosci. 22: 283–287.
- Ikram-ul-Haq, Ali S., Qadeer, M.A. (2002). Biosynthesis of L-DOPA by Aspergillus oryzae. Bioresour Technol. 85: 25–29.
- Johirul, M., Shiddiky, A., Kim, R.E. (2005). Microchip capillary electrophoresis with a cellulose-DNA-modified screen-printed electrode for the analysis of neurotransmitters. Electrophoresis 26: 3043–3052.
- Wang, J., Zhou, Y., Wang, A.F. (2005). Determination of levodopa methyl ester and its metabolites in rat serum by CZE with amperometric detection. Anal Bioanal Chem. 382: 198–203.
- Blanco, M., Valverde, I. (2003). Chiral and non chiral determination of Dopa by capillary electrophoresis. J Pharm Biomed Anal. 31: 431–438.
- Lunte, S.M., O'Shea, T.J. (1994). Pharmaceutical and biomedical applications of capillary electrophoresis/electrochemistry. Electrophoresis 15: 79–86.
- Napolitano, A., Del, Dotto, P., Petrozzi, L. (1999). Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson's disease. Clin. Neuropharmacol 22: 24–29.
- Zhiquan, Z., Yong, S., Qiqing, Z., , et al. (2005). Assay of CCNU in tumor by RP-HPLC. Artificial Cells, Blood Substitutes, and Immobilization Biotechnology 33: 371–375.
- Chen, X., Xie, J., Li, C. (2004). Investigation of the factors that induce analyte peak splitting in capillary electrophoresis. J Sep Sc. 27: 1005–1010.